Authors
Latest:
Analyzing FLIO data from the AI-READI project with Aaron Y. Lee, MD, MSCIFluorescence lifetime imaging ophthalmoscopy is emerging as a valuable tool to reveal previously hidden links between retinal changes and systemic disease.
Latest:
New presbyopia-correcting IOL provides spectacle independenceLens combines diffractive multifocal and extended depth-of-focus properties.
Latest:
tPA: A (new) tool in the uveitis armamentarium for patient careIntracameral tPA can treat fibrinous clots in severe anterior uveitis.
Latest:
Assessing the quality of real-world evidence in retinal diseasesReal-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.
Latest:
ARVO 2025: Analysis of birdshot retinochoroidopathy.At ARVO 2025, in Salt Lake City, Utah, C Michael Samson, MD, MBA, gave insight into his data on immune cell profiling in birdshot retinochoroidopathy using single-cell RNA sequencing.
Latest:
The ABCs of canaloplastyNot only is canaloplasty designed to treat the entire conventional outflow pathway, facilitating flow through the trabecular meshwork, Schlemm canal, and collector channels, but it does so without a stent and without removing tissue.
Latest:
Envision Summit 2025: How to use the new G2211 codeAt the Envision Summit 2025 in San Juan, Puerto Rico, Lana Rifkin, MD, gave clinicians advice on how, and when it may be most appropriate to use the new G2211 code.
Latest:
Q&A: Priya S. Vakharia, MD, shares insight into the Phase 2 ARCHER trial for GAVakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and future directions in ophthalmology.
Latest:
Pigskins and perception: How neuro-ophthalmology influences NFL refereesEvery football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Latest:
Q&A: Siegfried Priglinger, MD, on the long-term outcomes of gene therapy in preschool kidsSiegfried Priglinger, MD discussed research he presented focused on pediatric patients with inherited retinal diseases with an emphasis on studies into the RPE65 gene.
Latest:
Envision Summit 2025: Surgical challenges of a pediatric retinal detachment secondary to traumaAt the Envision Summit 2025 in San Juan, Puerto Rico, Nita Valikodath, MD, MS, gave insight into a challenging case of a 14-year-old boy who had trauma-related retinal detachment in his right eye, where a further macula-on retinal detachment with retinal dialysis was found in the left.
Latest:
Seeking a solution to the anesthesia provider shortageOffice-based surgery could prove to be a viable option for physicians.
Latest:
Future of Intravitreal InjectionNadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Latest:
ARVO 2025: Association between ocular and systemic mitochondrial diseases and dementiaAt ARVO 2025, in Salt Lake City, Utah, Viha Vig, talked about her poster presentation investigating the relationship between ocular and systemic mitochondrial diseases and dementia
Latest:
ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents AI-driven digital twin for simulation of aging eyeThe Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize presbyopia treatment across the lifecycle.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
The relationship between myopia and conjunctival-scleral geometryNasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
Latest:
New IOLs for keratoconus and other aberrated corneasAnterior segment surgeon expands on the use of the XtraFocus pinhole implant.
Latest:
Focus on molecular mechanisms underlying cataract developmentSeveral hundred genes are associated with congenital forms.
Latest:
What ophthalmologists need to know about neuromyelitis optica spectrum disorderEarly diagnosis of NMOSD is key to preventing disability, improving survival.
Latest:
Electrical neurostimulation for glaucoma with Sunita Radhakrishnan, MDSunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.
Latest:
Froin syndrome: Eyes are the window to the spinePapilledema with back pain suggests spine lesion.
Latest:
50 years of ophthalmology: What changed the game (Part 1)In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Latest:
FDA approves Lenz Therapeutics’ VIZZ for the treatment of presbyopiaVizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
